ES2128404T3 - Derivados de dibekacina y derivados de arbekacina activos contra bacterias resistentes, y la produccion de los mismos. - Google Patents
Derivados de dibekacina y derivados de arbekacina activos contra bacterias resistentes, y la produccion de los mismos.Info
- Publication number
- ES2128404T3 ES2128404T3 ES93402870T ES93402870T ES2128404T3 ES 2128404 T3 ES2128404 T3 ES 2128404T3 ES 93402870 T ES93402870 T ES 93402870T ES 93402870 T ES93402870 T ES 93402870T ES 2128404 T3 ES2128404 T3 ES 2128404T3
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- amino
- dibekacina
- arbekacina
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
COMO NUEVOS DERIVADOS DE DIBEKACIN Y NUEVOS DERIVADOS DE ARBECACINA SON AHORA PROVISTOS 2"-AMINO-2"DEOXYDEBECACINA, 2"-AMINO-5,2"DIDEOXIDIBECACIN, 2"-AMINO-2"-DEOXIARBECACINA, 2"-AMINO5,2"DIDEOXIARBECACINA, 2"-AMINO-5,2"-DIDEOXI-5-EPI-FLUORARBECACINA Y 2"-AMINO-5.2"-DIDEOXI-5EPIAMINOARBEKACIN LO CUAL EXHIBE UNA ACTIVIDAD ANTIBACTERIAL ALTA CONTRA UNA AMPLIA VARIEDAD DE BACTERIAS GRAM-POSITIVA Y GRAM-NEGATIVA, INCLUYENDO RESISTENCIA A BACTERIA TAL COMO STAPHYLOCOCCUS AUREUS CON RESISTENCIA A METICILINA Y LOS CUALES TIENEN TOXICIDAD BAJA HACIA LOS MAMIFEROS Y SON UTILES COMO AGENTE ANTIBACTERIAL PARA EL TRATAMIENTO DE LAS INFECCIONES BACTERICIDAS.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34131492A JP3215732B2 (ja) | 1992-11-27 | 1992-11-27 | 耐性菌に有効なジベカシン誘導体またはアルベカシン誘導体とそれらの製造法 |
| JP24732793A JP3215759B2 (ja) | 1993-09-09 | 1993-09-09 | 耐性菌に有効な5−置換−2″−アミノ−2″−デオキシアルベカシンとその製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2128404T3 true ES2128404T3 (es) | 1999-05-16 |
Family
ID=26538214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93402870T Expired - Lifetime ES2128404T3 (es) | 1992-11-27 | 1993-11-26 | Derivados de dibekacina y derivados de arbekacina activos contra bacterias resistentes, y la produccion de los mismos. |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US5488038A (es) |
| EP (1) | EP0601909B1 (es) |
| DE (1) | DE69322750T2 (es) |
| ES (1) | ES2128404T3 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040058880A1 (en) * | 2002-07-01 | 2004-03-25 | Chang-Hsing Liang | Aminoglycoside antibiotics as novel anti-infective agents |
| EP1710248A4 (en) * | 2004-01-21 | 2009-05-27 | Meiji Seika Kaisha | NEW AMINOGLYCOSIDE ANTIBIOTICS WITH EFFECT ON METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) |
| US7794713B2 (en) * | 2004-04-07 | 2010-09-14 | Lpath, Inc. | Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| ES2392389T3 (es) | 2004-05-17 | 2012-12-10 | Gilead Sciences, Inc. | Combinación de fosfomicina/aminoglucósido aerosolizada para el tratamiento de las infecciones respiratorias bacterianas |
| GB0411948D0 (en) * | 2004-05-28 | 2004-06-30 | Univ Leeds | Compounds |
| CN102755634A (zh) * | 2005-08-29 | 2012-10-31 | 味之素株式会社 | 营养组合物 |
| US20090074720A1 (en) * | 2005-10-28 | 2009-03-19 | Sabbadini Roger A | Methods for decreasing immune response and treating immune conditions |
| US20080213274A1 (en) * | 2005-10-28 | 2008-09-04 | Sabbadini Roger A | Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye |
| US7862812B2 (en) * | 2006-05-31 | 2011-01-04 | Lpath, Inc. | Methods for decreasing immune response and treating immune conditions |
| US8791245B2 (en) * | 2008-10-03 | 2014-07-29 | Glycan Bioscience LLC | Anionic conjugates of glycosylated bacterial metabolite |
| JP5705136B2 (ja) * | 2010-02-03 | 2015-04-22 | 公益財団法人微生物化学研究会 | リードスルー誘導剤、及びナンセンス変異型遺伝性疾患治療薬 |
| CN116462721B (zh) * | 2023-04-18 | 2024-02-02 | 江南大学 | 抗菌性氨基糖苷衍生物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001208A (en) | 1972-10-06 | 1977-01-04 | Zaidan Hojin Biseibutsu Kagaku Kenkyo Kai | 1-N-[(S)-α-hydroxy-ω-aminoacyl] |
| US4107424A (en) * | 1972-10-06 | 1978-08-15 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | 1-N-[(S)-α-hydroxy-ω-aminoacyl] derivatives of 3',4'-dideoxykanamycin B and 3'-deoxykanamycin B antibiotics |
| US3974198A (en) | 1975-09-02 | 1976-08-10 | General Electric Company | Process for producing methyltriacetoxysilane |
| JPS6029720B2 (ja) * | 1975-12-11 | 1985-07-12 | 財団法人微生物化学研究会 | 3′,4′‐ジデオキシカナマイシンbの新規な製造法 |
| US4187372A (en) * | 1976-09-08 | 1980-02-05 | Abbott Laboratories | Seldomycin factor 5 derivative |
| IE48972B1 (en) | 1978-11-11 | 1985-06-26 | Microbial Chem Res Found | The production of a selectively protected n-acylated derivative of an aminoglycosidic antibiotic |
| JPS631319A (ja) | 1986-06-18 | 1988-01-06 | 多摩川精機株式会社 | Ac機器動作検出回路 |
| JPS6339891A (ja) * | 1986-08-04 | 1988-02-20 | Microbial Chem Res Found | 5−デオキシ−5−フルオロカナマイシンb誘導体とその製造法 |
| JPH0764866B2 (ja) * | 1987-02-24 | 1995-07-12 | 財団法人微生物化学研究会 | 1−n−(4−アミノ−3−フルオロ−2−ヒドロキシブチリル)カナマイシン類 |
-
1993
- 1993-11-18 US US08/154,002 patent/US5488038A/en not_active Expired - Lifetime
- 1993-11-26 EP EP93402870A patent/EP0601909B1/en not_active Expired - Lifetime
- 1993-11-26 DE DE69322750T patent/DE69322750T2/de not_active Expired - Fee Related
- 1993-11-26 ES ES93402870T patent/ES2128404T3/es not_active Expired - Lifetime
-
1995
- 1995-09-08 US US08/524,644 patent/US5618795A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0601909B1 (en) | 1998-12-23 |
| DE69322750D1 (de) | 1999-02-04 |
| EP0601909A2 (en) | 1994-06-15 |
| US5488038A (en) | 1996-01-30 |
| DE69322750T2 (de) | 1999-08-19 |
| US5618795A (en) | 1997-04-08 |
| EP0601909A3 (en) | 1997-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2067325T3 (es) | Amidas de factores del antibiotico ge 2270. | |
| PT806941E (pt) | Composicoes anti-bacterianas liposomicas de rigidez baixa | |
| DE3574106D1 (en) | Use of alkylglycosides as potentiators in antiseptic agents, and disinfectant and clearing agents with a bactericidal activity | |
| DE69942977D1 (de) | Pharmazeutische zusammenstellungen zur behandlung von hautzuständen | |
| AR017972A1 (es) | Composicion antimicrobiana, y uso de la misma para preparar una composicion para controlar staphylococcus aureaus (mrsa) y serratia marcescens atcc 14756 | |
| BRPI0514939A (pt) | método para matar ou inativar microorganismos no tecido de mamìfero, composição antimicrobiana, e, método para descolonizar pelo menos uma porção das cavidades nasais, narinas anteriores, e/ou nasofaringe de um indivìduo, para descolonizar pelo menos uma porção da cavidade esofágica de um indivìduo, para prevenir e/ou tratar uma aflição causada, ou agravada por, um organismo microbiano na pele e/ou membrana mucosal, para fornecer eficácia antimicrobiana residual em uma superfìcie, para prevenir e/ou de tratar um indivìduo para uma aflição respiratória causada por uma infecção microbiana, para tratar uma infecção de ouvido médio em um indivìduo, para tratar sinusite crÈnica em um indivìduo, para tratar impetigo na pele de um indivìduo, para tratar e/ou prevenir uma infecção no tecido de mamìfero, para tratar e/ou prevenir uma infecção na pele, no tecido mucosal, e/ou na ferida de um indivìduo, para fornecer eficácia antimicrobiana residual na pele, no tecido mucosal, e/ou em uma ferida de um indivìduo e para fazer uma composição antimicrobiana | |
| GT199800074A (es) | Derivados de la 9-oxima eritromicina. | |
| WO2005014585A8 (en) | Halogenated quinazolinyl nitrofurans as antibacterial agents | |
| PA8524501A1 (es) | Antibioticos macrolidos | |
| ES2162796T3 (es) | Proteinas biocidas. | |
| DE69809489D1 (de) | Lösungen als Träger für Augenarzneien | |
| ES2133722T3 (es) | Utilizacion de dextranos simples o conjugados para la fabricacion de un medicamento para prevenir o reducir el riesgo de infeccion de germenes patogenos bacterianos. | |
| GT198302370A (es) | Mejoras en o relativas a antibioticos | |
| ECSP056233A (es) | Nuevos derivados de lincomicina que poseen actividad antimicrobiana | |
| ATE272397T1 (de) | Selektive antibakterielle zusammensetzungen | |
| KR950026524A (ko) | 피부질환 치료용 의약조성물 | |
| MXPA02007371A (es) | Utilizacion de compuestos tipo retinoide como agentes antibacterianos. | |
| ES2144154T3 (es) | Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica. | |
| ES2056577T3 (es) | Composicion biocida y uso. | |
| AR018335A1 (es) | Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero | |
| AR039727A1 (es) | Difluorotioacetamidas de oxazolidinonas como agentes antibacterianos y composicion farmaceutica en base a ellas | |
| Kobayashi et al. | Brief Report Bactericidal Effects of Antiseptics and Disinfectants Against Methicillin-Resistant Staphylococcus aureus | |
| ES468662A1 (es) | Procedimiento para producir derivados cefalosporinicos de utilidad terapeutica | |
| ES2108149T3 (es) | Derivado de cefalosporina. | |
| AR025379A1 (es) | 9a-azalidas con actividad antibacteriana. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 601909 Country of ref document: ES |